Literature DB >> 8176146

Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease.

T Yamada1, T Aizawa, Y Koizumi, I Komiya, K Ichikawa, K Hashizume.   

Abstract

OBJECTIVE: To determine whether there is an age-related difference in the therapeutic response to antithyroid drugs in hyperthyroid Graves' disease.
DESIGN: Retrospective analysis of treatment duration and recurrence rate. PATIENTS: Two hundred and twenty-two patients who have triiodothyronine-suppressible thyroids within 4 years of methimazole treatment. MEASUREMENTS: Serum thyroid hormone levels, serum thyrotropin receptor antibody titer, and thyroidal radioiodine uptake. MAIN
RESULTS: A longer period of methimazole treatment was needed to normalize serum thyroid hormone levels and to restore normal thyroidal triiodothyronine suppressibility in young than in aged patients. There was an average 10-month lag between normalization of thyrotropin receptor antibody titer and restoration of thyroidal triiodothyronine suppressibility in both young and aged patients. Recurrence after discontinuation of methimazole was more frequent in young than in aged patients.
CONCLUSIONS: Aged patients with hyperthyroid Graves' disease show a more favorable response to antithyroid drugs than young counterparts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176146     DOI: 10.1111/j.1532-5415.1994.tb04973.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Chemical stress induces the unfolded protein response in olfactory sensory neurons.

Authors:  Neeraja Sammeta; Timothy S McClintock
Journal:  J Comp Neurol       Date:  2010-05-15       Impact factor: 3.215

2.  Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.

Authors:  E Mazza; M Carlini; D Flecchia; A Blatto; O Zuccarini; S Gamba; S Beninati; M Messina
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

3.  Outcome of treatment of hyperthyroidism.

Authors:  I M Bringmann; B L van Leeuwen; G Hennemann; G J Beckett; A D Toft
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

4.  Predictors of long-term remission in patients with Graves' disease: a single center experience.

Authors:  Panagiotis Anagnostis; Fotini Adamidou; Stergios A Polyzos; Simoni Katergari; Eleni Karathanasi; Chrisanthi Zouli; Athanasios Panagiotou; Marina Kita
Journal:  Endocrine       Date:  2013-02-11       Impact factor: 3.633

5.  Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria.

Authors:  John Enyi Ejeh M; Karounwi Omotayo Ogunjobi; John Enyi Ejeh; Kayode Solomon Adedapo; Joshua F Eniojukan
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01

Review 6.  Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence.

Authors:  Jia Liu; Jing Fu; Yuan Xu; Guang Wang
Journal:  Int J Endocrinol       Date:  2017-04-25       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.